• Co-Diagnostics Inc CODX.OQ reported a quarterly adjusted loss of $4.06​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-7.20. The mean expectation of two analysts for the quarter was for a loss of $3.75 per share. Wall Street expected results to range from $-3.90 to $-3.60 per share.

• Revenue rose 190.3% to $145.95 thousand from a year ago; analysts expected $163.50 thousand.

• Co-Diagnostics Inc's reported EPS for the quarter was a loss of $4.06​.

• The company reported a quarterly loss of $9.14 million.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

This summary was machine generated from LSEG data May 15 at 12:33 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)